Triple

T21289789
Position Surface form Disambiguated ID Type / Status
Subject Paul Schimmel E524754 entity
Predicate coFounded P104 FINISHED
Object Sirtris Pharmaceuticals NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sirtris Pharmaceuticals | Statement: [Paul Schimmel, coFounded, Sirtris Pharmaceuticals]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Sirtris Pharmaceuticals
Context triple: [Paul Schimmel, coFounded, Sirtris Pharmaceuticals]
  • A. Sirtris Pharmaceuticals chosen
    Sirtris Pharmaceuticals was a biotechnology company focused on developing drugs that target sirtuins and cellular pathways related to aging and metabolic diseases.
  • B. Millennium Pharmaceuticals
    Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
  • C. Ariad Pharmaceuticals
    Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
  • D. Portola Pharmaceuticals
    Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
  • E. Vertex Pharmaceuticals
    Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b5171f6c8190a5d57201ede73811 completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e736d9467881908ec5b1dec76e6f5d completed April 21, 2026, 8:35 a.m.
Created at: April 16, 2026, 4:03 p.m.